Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL442746

CC[n+]1c2ccccc2nc2c(OCCCC(=O)O)cccc21.O=S(=O)([O-])C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 1/20 0.36
LTB4R2 Q9NPC1 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
CYSLTR2 Q9NS75 2/20 0.35
CYSLTR1 Q9Y271 2/20 0.35
KMT2A Q03164 3/20 0.35
LMNA P02545 2/20 0.35
HPGD P15428 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
KCNH2 Q12809 6/20 0.34
MEN1 O00255 2/20 0.34
HIF1A Q16665 1/20 0.34
NPC1 O15118 1/20 0.34
USP2 O75604 1/20 0.34
POLB P06746 1/20 0.34
RAB9A P51151 1/20 0.34
BLM P54132 1/20 0.34
NLRP3 Q96P20 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PPARD Q03181 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1258702 0.91 LTB4R (0.39) LTB4RLTB4R2FFAR4CYSLTR2CYSLTR1
Trifluoroacetic Acid SCHEMBL11902973 0.90 LTB4R (0.37) LTB4RLTB4R2FFAR4CYSLTR2CYSLTR1
Trifluoroacetic Acid SCHEMBL11902971 0.90 LTB4R (0.41) LTB4RLTB4R2FFAR4CYSLTR2CYSLTR1
SCHEMBL12377694 0.90 LTB4R (0.42) LTB4RLTB4R2CYSLTR2CYSLTR1KMT2A
Acetic Acid SCHEMBL1258682 0.88 LTB4R (0.40) LTB4RLTB4R2CYSLTR2CYSLTR1KMT2A
Acetic Acid SCHEMBL1258679 0.88 LTB4R (0.41) LTB4RLTB4R2CYSLTR2CYSLTR1KMT2A
SCHEMBL18803960 0.78 LMNA (0.42) LTB4RLTB4R2CYSLTR2CYSLTR1KMT2A
SCHEMBL18803958 0.77 FOLH1 (0.42) L3MBTL1
Trifluoromethanesulfonic Acid SCHEMBL15268656 0.77 MEN1 (0.51) KMT2ALMNAHPGDKCNH2MEN1
SCHEMBL18803964 0.77 MAPT (0.40) KMT2ALMNAHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994536-B1 STABILIZATION OF ENZYMES BY NICOTINIC ACID ROCHE DIABETES CARE GMBH (DE) 2017-06-14 EP claimed
EP-2823052-B1 COMPATIBLE SOLUTE ECTOINE AS WELL AS DERIVATIVES THEREOF FOR ENZYME STABILIZATION ROCHE DIABETES CARE GMBH (DE) 2016-10-26 EP claimed
US-20160108391-A1 REAGENT COMPOSITIONS HAVING PYRIDINE-CARBOXYLIC ACID-STABILIZED ENZYMES, AS WELL AS METHODS OF MAKING AND USING THE SAME ROCHE DIABETES CARE, INC. (US) 2016-04-21 US claimed
EP-2994536-A1 STABILIZATION OF ENZYMES BY NICOTINIC ACID Roche Diagnostics GmbH (DE) 2016-03-16 EP claimed
US-20140363835-A1 COMPATIBLE SOLUTE ECTOINE AS WELL AS DERIVATIVES THEREOF FOR ENZYME STABILIZATION ROCHE DIABETES CARE, INC. 2014-12-11 US claimed
EP-2636750-A1 Compatible solute ectoine as well as derivatives thereof for enzyme stabilization Roche Diagniostics GmbH (DE) 2013-09-11 EP claimed
EP-4481375-A2 DETECTION REAGENTS AND ELECTRODE ARRANGEMENTS FOR MULTI-ANALYTE DIAGNOSTIC TEST ELEMENTS, AS WELL AS METHODS OF USING THE SAME F. Hoffmann-La Roche AG (CH) 2024-12-25 EP disclosed
EP-3523639-B1 DETECTION REAGENTS AND ELECTRODE ARRANGEMENTS FOR MULTI-ANALYTE DIAGNOSTIC TEST ELEMENTS, AS WELL AS METHODS OF USING THE SAME HOFFMANN LA ROCHE (CH) 2024-12-18 EP disclosed
US-20240327892-A1 DETECTION REAGENTS AND ELECTRODE ARRANGEMENTS FOR MULTI-ANALYTE DIAGNOSTIC TEST ELEMENTS, AS WELL AS METHODS OF USING THE SAME ROCHE DIABETES CARE, INC. 2024-10-03 US disclosed
US-12024735-B2 Detection reagents and electrode arrangements for multi-analyte diagnostic test elements, as well as methods of using the same ROCHE DIABETES CARE, INC. (US) 2024-07-02 US disclosed
US-20220098636-A1 DETECTION REAGENTS AND ELECTRODE ARRANGEMENTS FOR MULTI-ANALYTE DIAGNOSTIC TEST ELEMENTS, AS WELL AS METHODS OF USING THE SAME ROCHE DIABETES CARE, INC. (US) 2022-03-31 US disclosed
US-11230727-B2 Detection reagents and electrode arrangements for multi-analyte diagnostic test elements, as well as methods of using the same ROCHE DIABETES CARE, INC. (US) 2022-01-25 US disclosed
US-11220674-B2 Stabilization of dehydrogenases with stable coenzymes ROCHE DIABETES CARE, INC. (US) 2022-01-11 US disclosed
WO-2011020856-A1 STABILIZATION OF ENZYMES USING STABLE COENZYMES F. HOFFMANN-LA ROCHE AG (CH) 2011-02-24 WO disclosed
EP-2286725-A1 Method for producing an analytical magazine Roche Diagnostics GmbH (DE) 2011-02-23 EP disclosed
EP-2287605-A1 Simplified magazining of integrated systems Roche Diagnostics GmbH (DE) 2011-02-23 EP disclosed
EP-2245152-A1 STABILIZATION OF DEHYDROGENASES USING STABLE COENZYMES F. Hoffmann-La Roche AG (CH) 2010-11-03 EP disclosed
WO-2010094426-A1 METHOD FOR PRODUCING AN ANALYTICAL MAGAZINE ROCHE DIAGNOSTICS GMBH (DE) 2010-08-26 WO disclosed
WO-2010094427-A2 COMPACT STORAGE OF AUXILIARY ANALYTICAL DEVICES IN A CARTRIDGE ROCHE DIAGNOSTICS GMBH 2010-08-26 WO disclosed
WO-2009103540-A1 STABILIZATION OF DEHYDROGENASES USING STABLE COENZYMES F. HOFFMANN - LA ROCHE AG (CH) 2009-08-27 WO disclosed